Tech.euEurope
Biomatter lands $18M to speed up enzyme development with AI

Biomatter , a company specialising in custom enzyme design, has raised $18 million in an oversubscribed Series A funding round led by Astanor , with participation from existing investors UVC Partners…
Read at Tech.eu ↗Related

EuropeNebuly raises $21M Series A to turn AI investments into measurable results Tech.eu

EuropeAnorak secures $5M to let anyone create their own AI-powered games Tech.eu

EuropeLightspeed and Alphabet's CapitalG back Fractile in £500M plus funding round Tech.eu

EuropeCherry Ventures backs Tano with $4M to challenge the traditional influencer agency model Tech.eu

EuropeEuropean chips funding almost quadruples as investors back Nvidia’s inference challengers Sifted
